Schrodinger Inc. Common Stock (SDGR)

About SDGR

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

850

Website

www.schrodinger.com

Fundamentals

1-day range

$19.54$20.33

Market cap

$1.14B

P/E (trailing)

—

P/E (forward)

-14.59

EPS (trailing)

$-0.74

Dividend yield

—

Beta

1.70

Avg. volume

1.23M

Forecasts

7 analyst ratings

Schrodinger Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• SDGR

  Schrodinger Inc. Common Stock

  $19.7

  ▼ 3.48%
  Market cap $1.14BP/E —
  $10.95$23.02
• CRVS

  Corvus Pharmaceuticals Inc. Common Stock

  $14.15

  ▼ 3.87%
  Market cap $1.12BP/E —
  $5.28$26.95
• SVRA

  Savara Inc. Common Stock

  $5.27

  ▼ 4.10%
  Market cap $1.09BP/E —
  $3.19$7.01
• MNKD

  MannKind Corporation Common Stock

  $3.96

  ▼ 2.59%
  Market cap $1.21BP/E —
  $2.23$6.51
• LBRX

  LB Pharmaceuticals Inc Common Stock

  $47.8

  ▼ 0.20%
  Market cap $1.23BP/E —
  $13.36$50.16
• ARDX

  Ardelyx Inc. Common Stock

  $3.81

  ▼ 0.26%
  Market cap $1.23BP/E —
  $3.73$8.4
• ETON

  Eton Pharmaceuticals Inc. Common Stock

  $59.79

  ▼ 4.60%
  Market cap $1.24BP/E 150.92
  $14.27$66.37

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Schrodinger Sees FY Drug Discovery Revenue At $65M-$75M
  benzinga · 8/5/2026

Institutional Ownership

March 31, 2026

Total shares held

62.05M

Total value held

$687.74M

Institutional holders

222